The National Institute for Health and Care Excellence is backing routine NHS use of Amgen’s Kyprolis as an option for treating patients with multiple myeloma at first relapse. In a Final Appraisal Determination, the Institute has recommended the drug in combination with dexamethasone for adults with relapsed multiple myeloma (RMM) who have received one prior
Novartis has entered a clinical research collaboration with Bristol-Myers Squibb to investigate the safety, tolerability, and efficacy of Mekinist in combination with Opdivo and Opdivo + Yervoy regimen. The cancer treatments are being used as a potential option for metastatic colorectal cancer in patients with microsatellite stable tumours where the tumours are proficient in mismatch
Patients with severe and uncontrolled asthma found that taking AstraZeneca’s experimental drug benralizumab in a late-stage study either significantly reduced the need or stopped altogether their intake of oral corticosteroids (OCS), the drug was also shown to dramatically cut related hospitalisations.
The US biotech announces that it has licensed a late-stage stroke drug that could be the first treatment advancement in the therapy area since the 1990s. Biogen will pay Remedy Pharmaceuticals $120 million for Cirara, which is currently heading towards Phase III trials in ischaemic stroke. If Ciara makes it to the market, it could
As European Union leaders prepare for Brexit negotiations with the UK, Ireland has stepped up its bid to make Dublin the new home of the EU’s medicines agency. The EMA looks relatively certain to leave its current residence in east London because of Brexit, and many EU cities are eager to be chosen as the
Report by The Patient Association in association with Danish pharmaceutical company, LEO Pharma, has highlighted a significant gap between training and support available for primary care and needs of those living with psoriasis in the UK and Ireland.
A Cancer Research UK funded study published in the British Journal of General Practice has found more than one third (34%) of patients are diagnosed with cancer as an emergency in England had not visited their GP beforehand, which is hindering their chances of achieving the best treatment outcomes. Data collected from more than 4,600
The BMA is urging politicians to take on the NHS crisis in their pre-general election manifestos. Prime Minister Theresa May announced earlier this week that there will be a snap general election in the UK on June 8th, to “secure the strong and stable leadership the country needs to see us through Brexit and beyond”.
Scotland is set to become the first UK nation to routinely offer HIV pre-exposure prophylaxis to eligible patients after the Scottish Medicines Consortium backed the use of Gilead’s Truvada along with four other new therapies to be funded by the NHS. In clinical trials Truvada (emtricitabine/tenofovir disoproxil) was revealed to cut the relative risk of
UK-based GW Pharmaceuticals’ cannabinoid Epidiolex has been awarded Orphan status by European regulators as treatment for Lennox-Gastaut Syndrome (LGS), a rare and severe form of childhood-onset epilepsy. The approval follows data from two late-stage trials that showed when Epidiolex was added as an adjunct to patients’ current treatment, there was a significant reduction in the